Identifying High-Risk Features and Improving Follow-Up Strategies in Thin Melanoma: A Retrospective Cohort Study.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Clincal and Experimental Dermatology

• Publication date

  2025-11-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ced/llaf499PMID 41208524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topographical and Chronological Analysis of Thin Cutaneous Melanoma’s Progressions: A Multicentric Study

  2023cited by this paper
• Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.

  2020cited by this paper
• Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.

  2019cited by this paper
• Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers.

  2019cited by this paper
• Trends in incidence of thick, thin and in situ melanoma in Europe.

  2018cited by this paper
• Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

  2017cited by this paper
• Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis

  2017cited by this paper
• Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis.

  2015cited by this paper
• No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report

  2015cited by this paper
• The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma

  2015cited by this paper
• Thin melanoma.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• The classification of cutaneous melanoma.

  2009cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Prognosticators of melanoma, the melanoma report, and the sentinel lymph node

  2006cited by this paper
• Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

  2005cited by this paper
• Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

  2003cited by this paper
• Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

  2001cited by this paper
• Clinico‐pathological features of relapsing very thin melanoma

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth Phase

  2000cited by this paper
• Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

  1997cited by this paper
• "Thin" malignant melanoma: risk factors and clinical management.

  1992cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma

  1970cited by this paper

• No citing papers are available for this paper.